Anti-Pfs25 human plasma reduces transmission of plasmodium falciparum isolates that have diverse genetic backgrounds

Pfs25 is a leading candidate for a malaria transmission-blocking vaccine whose potential has been demonstrated in a phase 1 trial with recombinant Pfs25 formulated with Montanide ISA51. Because of limited sequence polymorphism, the anti-Pfs25 antibodies induced by this vaccine are likely to have tra...

Full description

Saved in:
Bibliographic Details
Main Authors: Dari F. Da, Saurabh Dixit, Jetsumon Sattabonkot, Jianbing Mu, Luc Abate, Bhanumati Ramineni, Jean Bosco Ouedraogo, Nicholas J. MacDonald, Michael P. Fay, Xin zhuan Su, Anna Cohuet, Yimin Wu
Other Authors: Institut de Recherche en Sciences de la Santé (IRSS)
Format: Article
Published: 2018
Subjects:
Online Access:https://repository.li.mahidol.ac.th/handle/123456789/31917
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Mahidol University